Michael Gelband’s Helen of Troy HELE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,457
Closed -$367K 1772
2026
Q1
$367K Sell
25,457
-21,663
-46% -$379K ﹤0.01% 1267
2025
Q4
$1M Buy
47,120
+33,504
+246% +$684K 0.01% 999
2025
Q3
$343K Buy
+13,616
New +$330K ﹤0.01% 1272
2025
Q2
Sell
-34,830
Closed -$1.86M 1668
2025
Q1
$1.86M Buy
+34,830
New +$2.01M 0.02% 718
2023
Q3
Sell
-18,527
Closed -$2M 1875
2023
Q2
$2M Buy
+18,527
New +$1.77M 0.02% 802
2022
Q4
Sell
-30,647
Closed -$2.96M 1827
2022
Q3
$2.96M Buy
30,647
+15,331
+100% +$1.97M 0.04% 605
2022
Q2
$2.49M Buy
15,316
+10,695
+231% +$2.02M 0.03% 688
2022
Q1
$905K Buy
+4,621
New +$973K 0.01% 1222
2021
Q2
Sell
-3,727
Closed -$785K 2536
2021
Q1
$785K Buy
+3,727
New +$840K 0.01% 1063
2020
Q2
Sell
-4,723
Closed -$680K 1873
2020
Q1
$680K Buy
4,723
+3,123
+195% +$529K 0.04% 396
2019
Q4
$288K Buy
+1,600
New +$257K 0.01% 1161

Other funds holding HELE

Michael Gelband's HELE Position: Q2 2026 in Review

Michael Gelband sold out of Helen of Troy (HELE) in Q2 2026, closing a stake of 25,457 shares — an estimated $367K sold.

Michael Gelband first reported a position in HELE in Q4 2019 and held it in 11 quarters. The position peaked at $2.96M in Q3 2022. 199 funds tracked by Wall St. Rank hold HELE as of Q2 2026.

  • Michael Gelband reported no remaining Helen of Troy position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 25,457 Helen of Troy shares in Q2 2026, an estimated $367K.
  • Michael Gelband first reported a position in Helen of Troy in Q4 2019 and held it in 11 quarters.
  • Michael Gelband's Helen of Troy position peaked at $2.96M in Q3 2022.
  • 199 funds tracked by Wall St. Rank held Helen of Troy as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.